Coronary Artery Aneurysms in ST-Elevation Myocardial Infarction (From a United States Based National Cohort)

Khalid Changal1, Tanveer Mir2, Rachel Royfman3

  • 1Cardiovascular Medicine, University of Toledo College of Medicine and Life Sciences, Ohio.

Insights

Patients with ST-elevation myocardial infarction (STEMI) and coronary artery aneurysms (CAA) are younger, more likely male, and have lower mortality. This study highlights key differences in STEMI patients with and without CAA.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Epidemiology

Background:

  • The relationship between coronary artery aneurysms (CAA) and ST-elevation myocardial infarction (STEMI) is not well understood.
  • Identifying differences in patient profiles and outcomes is crucial for managing STEMI with co-existing CAA.

Purpose of the Study:

  • To investigate and compare patient demographics, clinical characteristics, interventions, and mortality in patients with STEMI, stratified by the presence or absence of CAA.
  • To elucidate potential differences in the underlying pathophysiology and management strategies for STEMI associated with CAA.

Main Methods:

  • Retrospective analysis of the Nationwide Readmission database (2014-2018).
  • Inclusion of 1,038,299 patients with STEMI, with 1,543 (0.15%) identified as having CAA.
  • Comparison of primary outcome (mortality) and secondary outcomes (clinical presentation, interventions, coronary dissection) between the CAA and no-CAA groups.

Main Results:

  • Patients with STEMI and CAA were younger (62.6 vs 65.4 years), more frequently male (78% vs 66%), and had a higher prevalence of prior Kawasaki disease (2.5% vs 0.01%).
  • Coronary dissection was significantly more prevalent in the CAA group (73% vs 1%).
  • The CAA group showed lower all-cause mortality (6.3% vs 11.7%) despite increased use of coronary artery bypass grafting, thrombectomy, and bare-metal stents.

Conclusions:

  • Significant differences exist in the clinical profile, risk of coronary dissection, treatment approaches, and mortality for STEMI patients with CAA compared to those without.
  • These findings underscore the need for tailored management strategies for STEMI patients with co-existing coronary artery aneurysms.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
98
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
36
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
67
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
38